HopeStage
Back to all studies
CompletedNCT01514422

Minocycline Added to Mood Stabilizers for Depression Related to Bipolarity

About this title

Minocycline for Bipolar Depression

Read the official source — NCT01514422
Medication studyAges 18–68United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 68 years.

Listed locations
New YorkSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateMay 2011
Recruitment status
Completed
Enrollment listed in the registry
20
Sponsor
Icahn School of Medicine at Mount Sinai
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 68 Years
Official registry ID
NCT01514422
Official title
Show the full official title

Minocycline for Bipolar Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

New York

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Icahn School of Medicine at Mount Sinai, a university.

Did this study involve medication?

Yes. The study involved medication, including Minocycline.

Who was this study for?

Listed age limits: 18 years to 68 years.

Want to explore more studies?

Explore studies